Measuring affinity constants of 1450 monoclonal antibodies to peptide targets with a microarray-based label-free assay platform.

Monoclonal antibodies (mAbs) are major reagents for research and clinical diagnosis. For their inherently high specificities to intended antigen targets and thus low toxicity in general, they are pursued as one of the major classes of new drugs. Yet binding properties of most monoclonal antibodies are not well characterized in terms of affinity constants and how they vary with presentations and/or conformational isomers of antigens, buffer compositions, and temperature. We here report a microarray-based label-free assay platform for high-throughput measurements of monoclonal antibody affinity constants to antigens immobilized on solid surfaces. Using this platform we measured affinity constants of over 1410 rabbit monoclonal antibodies and 46 mouse monoclonal antibodies to peptide targets that are immobilized through a terminal cysteine residue to a glass surface. The experimentally measured affinity constants vary from 10 pM to 200 pM with the median value at 66 pM. We compare the results obtained from the microarray-based platform with those from a benchmarking surface-plasmon-resonance-based (SPR) sensor (Biacore 3000).

[1]  N. Sewald,et al.  Real-Time Analysis of Specific Protein-DNA Interactions with Surface Plasmon Resonance , 2012, Journal of amino acids.

[2]  G. Kobinger,et al.  Transmission of Ebola virus from pigs to non-human primates , 2012, Scientific Reports.

[3]  Christian Bailly,et al.  Strategies and challenges for the next generation of therapeutic antibodies , 2010, Nature Reviews Immunology.

[4]  Xi Chen,et al.  An optics-based variable-temperature assay system for characterizing thermodynamics of biomolecular reactions on solid support. , 2013, The Review of scientific instruments.

[5]  K. Lam,et al.  A novel high-throughput scanning microscope for label-free detection of protein and small-molecule chemical microarrays. , 2008, The Review of scientific instruments.

[6]  Louis M. Weiner,et al.  Monoclonal antibodies: versatile platforms for cancer immunotherapy , 2010, Nature Reviews Immunology.

[7]  Kit S. Lam,et al.  Oblique-incidence reflectivity difference microscope for label-free high-throughput detection of biochemical reactions in a microarray format. , 2007 .

[8]  Y.S. Sun,et al.  Effect of fluorescently labeling protein probes on kinetics of protein-ligand reactions , 2008, 2008 Conference on Lasers and Electro-Optics and 2008 Conference on Quantum Electronics and Laser Science.

[9]  Laurent Bélec,et al.  Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis , 2007, Proceedings of the National Academy of Sciences.

[10]  J. Perkel,et al.  The antibody challenge. , 2014, BioTechniques.

[11]  Ingemar Lundström,et al.  Bioanalysis with surface plasmon resonance , 1991 .

[12]  J. Strong,et al.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™ , 2014, Nature.

[13]  Xiangdong Zhu,et al.  Simultaneous measurement of 10,000 protein-ligand affinity constants using microarray-based kinetic constant assays. , 2012, Assay and drug development technologies.

[14]  Xiangdong Zhu,et al.  Comparison of two optical techniques for label-free detection of biomolecular microarrays on solids , 2006 .